
Kishor Mayekar
Examiner (ID: 18425, Phone: (571)272-1339 , Office: P/1759 )
| Most Active Art Unit | 1795 |
| Art Unit(s) | 1759, 1102, 1741, 1754, 1795, 2741, 1753 |
| Total Applications | 2436 |
| Issued Applications | 1650 |
| Pending Applications | 176 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 545199
[patent_doc_number] => 07169918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-30
[patent_title] => 'Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/970641
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13176
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/169/07169918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970641 | Methods for preparing 7-(2′-substituted-β-D-ribofuranosyl)-4-(NR2R3)-5-(substituted ethyn-1-yl)-pyrrolo[2,3-d]pyrimidine derivatives | Oct 19, 2004 | Issued |
Array
(
[id] => 7105071
[patent_doc_number] => 20050107312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Nucleoside compounds for treating viral infections'
[patent_app_type] => utility
[patent_app_number] => 10/970321
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14797
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10970321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/970321 | Nucleoside compounds for treating viral infections | Oct 19, 2004 | Issued |
Array
(
[id] => 7084028
[patent_doc_number] => 20050049408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Oligonucleotide N3\'->P5\' thiophosphoramidates: their synthesis and use'
[patent_app_type] => utility
[patent_app_number] => 10/967755
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15871
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967755
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967755 | Treating cancer using an oligonucleotide N3′->N5′ thiophosphoramidate | Oct 17, 2004 | Issued |
Array
(
[id] => 7163183
[patent_doc_number] => 20050085442
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Use of mannan from saccharomyces cerevisiae for the treatment of asthma'
[patent_app_type] => utility
[patent_app_number] => 10/962785
[patent_app_country] => US
[patent_app_date] => 2004-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 6825
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085442.pdf
[firstpage_image] =>[orig_patent_app_number] => 10962785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/962785 | Use of mannan from saccharomyces cerevisiae for the treatment of asthma | Oct 11, 2004 | Issued |
Array
(
[id] => 7256214
[patent_doc_number] => 20050143329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Indole antiviral compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/959885
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29646
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143329.pdf
[firstpage_image] =>[orig_patent_app_number] => 10959885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/959885 | Indole antiviral compositions and methods | Oct 5, 2004 | Issued |
Array
(
[id] => 8028301
[patent_doc_number] => 08143234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function'
[patent_app_type] => utility
[patent_app_number] => 10/944269
[patent_app_country] => US
[patent_app_date] => 2004-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 17422
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143234.pdf
[firstpage_image] =>[orig_patent_app_number] => 10944269
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/944269 | Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function | Sep 19, 2004 | Issued |
Array
(
[id] => 7172257
[patent_doc_number] => 20050203053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function'
[patent_app_type] => utility
[patent_app_number] => 10/941025
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16978
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203053.pdf
[firstpage_image] =>[orig_patent_app_number] => 10941025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/941025 | Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function | Sep 14, 2004 | Abandoned |
Array
(
[id] => 5771605
[patent_doc_number] => 20050267056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/942319
[patent_app_country] => US
[patent_app_date] => 2004-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9231
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267056.pdf
[firstpage_image] =>[orig_patent_app_number] => 10942319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/942319 | Synthesis and manufacture of pentostatin and its precursors, analogs and derivatives | Sep 14, 2004 | Abandoned |
Array
(
[id] => 6997742
[patent_doc_number] => 20050137391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Process for the synthesis of oligomeric compounds'
[patent_app_type] => utility
[patent_app_number] => 10/940360
[patent_app_country] => US
[patent_app_date] => 2004-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13466
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137391.pdf
[firstpage_image] =>[orig_patent_app_number] => 10940360
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/940360 | Process for the synthesis of oligomeric compounds | Sep 13, 2004 | Issued |
Array
(
[id] => 4834147
[patent_doc_number] => 20080132694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Method For Facilitating an Automated Isolation of a Biopolymer Using Magnetic Particles'
[patent_app_type] => utility
[patent_app_number] => 10/567351
[patent_app_country] => US
[patent_app_date] => 2004-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6603
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567351
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567351 | Method for facilitating an automated isolation of a biopolymer using magnetic particles | Aug 15, 2004 | Issued |
Array
(
[id] => 7117305
[patent_doc_number] => 20050070606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-31
[patent_title] => 'Pharmaceutical agent for mitochondrial disorders'
[patent_app_type] => utility
[patent_app_number] => 10/917473
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5067
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20050070606.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917473
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917473 | Pharmaceutical agent for mitochondrial disorders | Aug 12, 2004 | Abandoned |
Array
(
[id] => 7089665
[patent_doc_number] => 20050009778
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Method for treating retinal degeneration with purinergic receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/916086
[patent_app_country] => US
[patent_app_date] => 2004-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8303
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009778.pdf
[firstpage_image] =>[orig_patent_app_number] => 10916086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/916086 | Method for treating retinal degeneration with purinergic receptor agonists | Aug 9, 2004 | Abandoned |
Array
(
[id] => 813763
[patent_doc_number] => 07414036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-08-19
[patent_title] => 'Compounds useful as A3 adenosine receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/899625
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 25802
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/414/07414036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899625
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899625 | Compounds useful as A3 adenosine receptor agonists | Jul 25, 2004 | Issued |
Array
(
[id] => 7437893
[patent_doc_number] => 20040267005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Method for large-scale production of di(uridine 5\')-tetraphosphate and salts thereof'
[patent_app_type] => new
[patent_app_number] => 10/895728
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6145
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20040267005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10895728
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/895728 | Method for large-scale production of di(uridine 5′)-tetraphosphate and salts thereof | Jul 19, 2004 | Issued |
Array
(
[id] => 7264995
[patent_doc_number] => 20040242531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Treatment of heart rhythm disturbances with N6-substituted-5\'-(N-substituted) carboxamidoadenosines'
[patent_app_type] => new
[patent_app_number] => 10/878041
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6058
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242531.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878041 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7276332
[patent_doc_number] => 20040235783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Pharmaceutical compositions for the treatment of tumor diseases'
[patent_app_type] => new
[patent_app_number] => 10/878383
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7429
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878383
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878383 | Pharmaceutical compositions for the treatment of tumor diseases | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7265394
[patent_doc_number] => 20040242930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Treatment of heart rhythm disturbances with N6-substituted-5\'-(N-substituted) carboxamidoadenosines'
[patent_app_type] => new
[patent_app_number] => 10/878031
[patent_app_country] => US
[patent_app_date] => 2004-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6056
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242930.pdf
[firstpage_image] =>[orig_patent_app_number] => 10878031
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/878031 | Treatment of heart rhythm disturbances with N6-substituted-5'-(N-substituted) carboxamidoadenosines | Jun 28, 2004 | Abandoned |
Array
(
[id] => 7318992
[patent_doc_number] => 20040224921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Fluorescent cobalamins and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/866988
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10180
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224921.pdf
[firstpage_image] =>[orig_patent_app_number] => 10866988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/866988 | Fluorescent cobalamins and uses thereof | Jun 14, 2004 | Issued |
Array
(
[id] => 7275148
[patent_doc_number] => 20040234599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Composition and method for maintaining healthy mobile joints and cartilage'
[patent_app_type] => new
[patent_app_number] => 10/865404
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8748
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20040234599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865404 | Composition and method for maintaining healthy mobile joints and cartilage | Jun 8, 2004 | Issued |
Array
(
[id] => 609585
[patent_doc_number] => 07151089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-19
[patent_title] => 'Nucleoside compounds for treating viral infections'
[patent_app_type] => utility
[patent_app_number] => 10/861219
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11650
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/151/07151089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10861219
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/861219 | Nucleoside compounds for treating viral infections | Jun 3, 2004 | Issued |